Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Edgewise Therapeutics Grants Stock Options and Restricted Stock Units to Two New Employees

By Public Technologies
  • Edgewise Therapeutics granted inducement equity awards to two new non-executive employees on October 30, 2026, under its 2024 Inducement Equity Incentive Plan.
  • Awards included stock options to purchase 17,250 common shares and restricted stock units covering 8,626 common shares.
  • Options vest 25% on each employee's first employment anniversary, followed by monthly vesting of 1/48th of the shares.
  • Restricted stock units vest 25% on each of the first four grant-date anniversaries; all vesting requires continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA86277) on November 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.